Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992575 · ClinicalTrials.gov registry record
OCT in Retinal Vein Occlusions
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 4
- Enrollment target
NCT01992575: Completed study, sponsored by Oregon Health and Science University.
NCT01992575 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992575 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Retinal blood vessel disease encompasses a wide variety of vision-threatening conditions. Of these conditions, retinal vein occlusions are the most common. Vision loss can occur as a result of macular ischemia (loss of blood flow to the macula) or macular edema (fluid build-up at the macula). OCT is an imaging technology that can perform non-contact cross-sectional imaging of retinal and choroidal tissue structures in real time. It is similar to ultrasound imaging, except that OCT measures the intensity of reflected light rather than sound waves. The purpose of this study is to see if non-invasive OCT technology can changes due to retinal vein occlusions as well as the more invasive fluorescein angiography, which requires an injection of dye into the vein of an arm of a patient. The study will also compare the mapping of blood vessels (angiography) and loss of blood flow (ischemia) by fluorescein angiography and OCT. These studies will be evaluated to see how they relate to vision loss.
Primary Outcome
To determine if identifying early changes in blood vessel patterns and ischemia will aid in early diagnosis and treatment of retinal vein occlusions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-08-21 |
What the finished NCT01992575 record still lists
NCT01992575 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01992575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01992575 about?
NCT01992575 is a clinical study titled "OCT in Retinal Vein Occlusions". Retinal blood vessel disease encompasses a wide variety of vision-threatening conditions. Of these conditions, retinal vein occlusions are the most common. Vision loss can occur as a result of macular ischemia (loss of blood flow to the macula) or macular edema (fluid build-up at the macula). OCT i...
What is the current status of trial NCT01992575?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2014-01. Estimated completion is 2018-08-21.
Who is sponsoring clinical trial NCT01992575?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia